Healthcare Innovation: Balancing Creativity with Skepticism
PureTech Health is a cross-disciplinary healthcare company, developing innovative products that could improve the lives of billions of patients. PureTech has a pipeline of 12 programs, seven of which are “growth stage” with external validation including strategic partnerships, outside funding, proof-of-concept or peer review in prestigious scientific journals. Three of PureTech’s advanced programs will have pivotal or registration study readouts in the next two years. PureTech also has a pipeline of ten “concept phase” initiatives resulting from review of more than 650 ideas annually. PureTech is focused on areas including immune and inflammatory disorders; cognitive and psychiatric disorders; diabetes and obesity; oncology; and infectious diseases, and has over 110 patents and patent applications. PureTech’s leading team and board, along with an advisory network of more than 50 expert founder-scientists and advisors across multiple disciplines, gives PureTech access to potentially ground-breaking science and technological innovation.
Andrew Miller, PhD, is a Venture Partner at PureTech and a co-founder of Tal Medical and Karuna Pharmaceuticals. Dr. Miller currently serves as the Chief Operating Officer for Tal Medical. He is a co-inventor of Karuna’s technology platform where he serves as a Board Member and acting Vice President of Strategy and Operations. Dr. Miller also serves on the Board of Directors and as the acting Chief Operating Officer for Entrega. He completed his doctoral work focusing on polymeric biomaterials at the Massachusetts Institute of Technology. In graduate school, he was awarded the National Defense Science and Engineering Graduate Fellowship and completed course work at the M.I.T. Sloan School of Management. Dr. Miller received his B.S. in Chemical Engineering from the University of Illinois at Urbana-Champaign and his Ph.D. in Chemical Engineering from M.I.T.